These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12163631)

  • 1. Potential for a specific neuroradiologic diagnosis of Alzheimer's disease.
    Blass JP
    J Nucl Med; 2002 Aug; 43(8):1052-3. PubMed ID: 12163631
    [No Abstract]   [Full Text] [Related]  

  • 2. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
    Shi J; Perry G; Berridge MS; Aliev G; Siedlak SL; Smith MA; LaManna JC; Friedland RP
    J Nucl Med; 2002 Aug; 43(8):1044-51. PubMed ID: 12163630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
    Nordberg A
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212
    [No Abstract]   [Full Text] [Related]  

  • 4. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
    Hardy J
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1539-40. PubMed ID: 15372211
    [No Abstract]   [Full Text] [Related]  

  • 5. Slow walking speed may be early sign of Alzheimer's in older people, study finds.
    Mayor S
    BMJ; 2015 Dec; 351():h6506. PubMed ID: 26634380
    [No Abstract]   [Full Text] [Related]  

  • 6. A copper radiopharmaceutical for diagnostic imaging of Alzheimer's disease: a bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-beta plaques.
    Lim S; Paterson BM; Fodero-Tavoletti MT; O'Keefe GJ; Cappai R; Barnham KJ; Villemagne VL; Donnelly PS
    Chem Commun (Camb); 2010 Aug; 46(30):5437-9. PubMed ID: 20556304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
    Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
    Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques.
    Neumaier B; Deisenhofer S; Fürst D; von Arnim CA; Thees S; Buck AK; Glatting G; Landwehrmeyer GB; Krause BJ; Müller HD; Sommer C; Reske SN; Mottaghy FM
    Nuklearmedizin; 2007; 46(6):271-80. PubMed ID: 18084683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer research forum live discussion: Imaging in Alzheimer's disease: the current state of affairs.
    J Alzheimers Dis; 2005 Mar; 8(4):387-92. PubMed ID: 16646142
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice.
    Katsouri L; Ashraf A; Birch AM; Lee KK; Mirzaei N; Sastre M
    Neurobiol Aging; 2015 Feb; 36(2):821-31. PubMed ID: 25457554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain.
    Chen X; Yu P; Zhang L; Liu B
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1442-5. PubMed ID: 18191400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 14. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphy with 123I-serum amyloid P component in Alzheimer disease.
    Lovat LB; O'Brien AA; Armstrong SF; Madhoo S; Bulpitt CJ; Rossor MN; Pepys MB; Hawkins PN
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):208-10. PubMed ID: 9772025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    J Med Chem; 2005 Sep; 48(19):5980-8. PubMed ID: 16162001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.
    Noda-Saita K; Yoneyama A; Shitaka Y; Hirai Y; Terai K; Wu J; Takeda T; Hyodo K; Osakabe N; Yamaguchi T; Okada M
    Neuroscience; 2006; 138(4):1205-13. PubMed ID: 16460878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloid imaging].
    Ishii K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):915-7. PubMed ID: 18210834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
    Huddleston DE; Small SA
    Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.